...
首页> 外文期刊>Molecular brain >Increased biological activity of protein Kinase C gamma is not required in Spinocerebellar ataxia 14
【24h】

Increased biological activity of protein Kinase C gamma is not required in Spinocerebellar ataxia 14

机译:脊髓小脑共济失调不需要增加蛋白激酶Cγ的生物活性14

获取原文

摘要

AbstractSpinocerebellar ataxia (SCA) is an autosomal dominant neurodegenerative disorder characterized by slowly progressive cerebellar dysfunction. Currently, 42 SCA types are known, some of which are caused by CAG repeat expansions, but others are caused by point mutations or deletions. Spinocerebellar ataxia type 14 (SCA14) is caused by missense mutations or deletions in the PRKCG gene, coding for protein kinase C gamma (PKCγ). It is still not well understood how these mutations eventually cause Purkinje cell dysfunction and death. Because PKCγ is a well characterized signaling protein highly expressed in Purkinje cells SCA14 offers the chance to better understand the pathogenesis of Purkinje cell dysfunction and death. Altered biological activity of PKCγ would be the simplest explanation for the disease phenotype. There are indeed indications that the enzymatic activity of mutated PKCγ proteins could be changed. Many mutations found in SCA14 families are located in the regulatory C1B and C1A domain, while a few mutations are also found in the C2 and in the catalytic C3 and C4 domains. For many of these mutations an increased enzymatic activity could be demonstrated in cell-based assays, but it remains unclear whether there is indeed an altered biological activity of the mutated PKCγ proteins within living Purkinje cells. In this study we used the dendritic morphology of developing Purkinje cells to detect increased biological activity of PKCγ after expression of different mutated PKCγ proteins. Our results indicate that two out of three known mutations in the catalytic domain of PKCγ did indeed show increased biological activity. On the other hand, none of the five tested mutations located in the regulatory C1 or the C2 domain showed an increased biological activity. Our findings indicate that SCA14 mutations located in different domains of the PRKCG gene cause SCA14 by different mechanisms and that an increased constitutive activity of PKCγ may be one, but cannot be the only mechanism to cause disease in SCA14.
机译:摘要脊髓小脑性共济失调(SCA)是一种常染色体显性遗传性神经退行性疾病,其特征是缓慢进行性小脑功能障碍。当前,已知42种SCA类型,其中一些是由CAG重复扩增引起的,而另一些是由点突变或缺失引起的。脊髓小脑共济失调14型(SCA14)是由PRKCG基因中的错义突变或缺失引起的,该基因编码蛋白激酶Cγ(PKCγ)。这些突变如何最终导致浦肯野细胞功能障碍和死亡,目前尚不十分清楚。由于PKCγ是在Purkinje细胞中高表达的特征明确的信号蛋白,SCA14提供了更好地了解Purkinje细胞功能障碍和死亡的发病机制的机会。 PKCγ生物学活性的改变将是疾病表型的最简单解释。确实有迹象表明突变的PKCγ蛋白的酶促活性可以改变。在SCA14家族中发现的许多突变位于调节性C1B和C1A域中,而在C2和催化性C3和C4结构域中也发现了一些突变。对于许多这些突变,可以在基于细胞的测定法中证明其酶活性增加,但是尚不清楚活的浦肯野细胞中突变的PKCγ蛋白是否确实具有改变的生物学活性。在这项研究中,我们使用发育中的浦肯野细胞的树突形态来检测不同突变的PKCγ蛋白表达后PKCγ的生物学活性增加。我们的结果表明,PKCγ催化域中三个已知突变中的两个确实显示出增加的生物活性。另一方面,位于调节性C1或C2域中的五个测试突变均未显示出增加的生物活性。我们的发现表明,位于PRKCG基因不同域中的SCA14突变通过不同的机制引起SCA14,而PKCγ的增强的本构活性可能是一种,但不是引起SCA14疾病的唯一机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号